Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 190

1.
2.

Effects of treatment on cardiovascular risk among smokeless tobacco users.

Allen SS, Hatsukami D, Jensen J, Grillo M, Bliss R.

Prev Med. 1995 Jul;24(4):357-62.

PMID:
7479625
5.

The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease.

Joseph AM, Norman SM, Ferry LH, Prochazka AV, Westman EC, Steele BG, Sherman SE, Cleveland M, Antonuccio DO, Hartman N, McGovern PG.

N Engl J Med. 1996 Dec 12;335(24):1792-8. Erratum in: N Engl J Med. 2007 Jun 14;356(24):2554. Antonnucio, DO [corrected to Antonuccio, DO].

6.

Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking.

Benowitz NL, Fitzgerald GA, Wilson M, Zhang Q.

J Am Coll Cardiol. 1993 Oct;22(4):1159-67.

7.

Effects of nicotine nasal spray on atherogenic and thrombogenic factors during smoking cessation.

Lúdvíksdóttir D, Blöndal T, Franzon M, Gudmundsson TV, Säwe U.

J Intern Med. 1999 Jul;246(1):61-6.

9.
10.

A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation.

Prochazka AV, Kick S, Steinbrunn C, Miyoshi T, Fryer GE.

Arch Intern Med. 2004 Nov 8;164(20):2229-33.

PMID:
15534159
11.

Dose-related cardiovascular and endocrine effects of transdermal nicotine.

Zevin S, Jacob P 3rd, Benowitz NL.

Clin Pharmacol Ther. 1998 Jul;64(1):87-95.

PMID:
9695723
12.

Changes in cardiovascular risk profile during the cessation of smoking.

Terres W, Becker P, Rosenberg A.

Am J Med. 1994 Sep;97(3):242-9.

PMID:
8092173
13.

A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation.

O'Malley SS, Cooney JL, Krishnan-Sarin S, Dubin JA, McKee SA, Cooney NL, Blakeslee A, Meandzija B, Romano-Dahlgard D, Wu R, Makuch R, Jatlow P.

Arch Intern Med. 2006 Mar 27;166(6):667-74.

PMID:
16567607
14.
15.
16.

Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation.

Davidson M, Epstein M, Burt R, Schaefer C, Whitworth G, McDonald A.

Arch Fam Med. 1998 Nov-Dec;7(6):569-74.

PMID:
9821833
17.

Weight change after smoking cessation using variable doses of transdermal nicotine replacement.

Dale LC, Schroeder DR, Wolter TD, Croghan IT, Hurt RD, Offord KP.

J Gen Intern Med. 1998 Jan;13(1):9-15.

18.

Effects of the transdermal nicotine patch on normalization of HDL-C and its subfractions.

Moffatt RJ, Biggerstaff KD, Stamford BA.

Prev Med. 2000 Aug;31(2 Pt 1):148-52.

PMID:
10938215
19.

The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day.

Daughton DM, Fortmann SP, Glover ED, Hatsukami DK, Heatley SA, Lichtenstein E, Repsher L, Millatmal T, Killen JD, Nowak RT, Ullrich F, Patil KD, Rennard SI.

Prev Med. 1999 Feb;28(2):113-8.

PMID:
10048102
20.

Weight gain and insulin resistance during nicotine replacement therapy.

Assali AR, Beigel Y, Schreibman R, Shafer Z, Fainaru M.

Clin Cardiol. 1999 May;22(5):357-60.

Supplemental Content

Support Center